TruAlt Bioenergy Ltd Q2 FY26 – From Ethanol King to Jet Fuel Joker? 3.6% Market Share, ₹2,250 Cr SAF MoU, and -₹38 Cr PAT!
1. At a Glance
TruAlt Bioenergy’s Q2 FY26 results have arrived — and they look like a hangover after an ethanol party. The company, once hailed as India’s largest ethanol producer with a 3.6% national market share, just posted a quarterly loss of ₹38 crore on revenue of ₹115 crore — a massive -70% collapse in sales QoQ and a -103% profit nosedive. Yes, negative. Even the CFO’s calculator must’ve short-circuited trying to justify that.
At ₹458 per share (as of 14 Nov 2025), TruAlt sits with a ₹3,927 crore market cap and a fancy P/E of 30.8, though with this quarter’s loss, “P/E not meaningful” would’ve been kinder. Its ROE at 28.4% and ROCE at 14.2% suggest solid fundamentals — but those are full-year metrics, not quarterly shocks. Debt stands tall at ₹1,546 crore, making the company’s debt-to-equity 1.10, slightly over-energized for a biofuel maker.
Like the Quran says, “Indeed, with hardship comes ease.” (94:6) — hopefully, TruAlt’s ethanol tanks find that ease soon.
The company just signed a ₹2,250 crore MoU with the Andhra Pradesh government to build an 80,000 TPA Sustainable Aviation Fuel (SAF) plant. Ambitious, but after this quarter’s wipeout, investors might be wondering: are we fueling airplanes or burning cash?
2. Introduction
TruAlt Bioenergy Limited’s Q2 FY26 report reads like a screenplay — part ambition, part chaos, full drama. In a sector powered by sugarcane juice and government ethanol blending targets, TruAlt has tried to mix every possible biofuel dream into one chemical cocktail: ethanol, CBG, SAF, ENA, CO₂, even biochemical ventures like Mevalonolactone (which sounds like a Marvel villain).
For a company that calls itself “India’s largest ethanol manufacturer,” it sure picked the wrong quarter to underdeliver — sales plunged from ₹304 crore in Q1 FY26 to just ₹115 crore in Q2 FY26, while operating margins crashed from +14% to -4%. Operating profit fell off a cliff — from ₹42 crore last quarter to a loss of ₹5 crore. That’s not a slowdown; that’s an ethanol engine stalling midair.
But the narrative is far from over. Between its ₹750 crore IPO earlier this year and big-ticket announcements like the SAF project, a Sumitomo JV for compressed biogas, and dual-feedstock upgrades, TruAlt seems to be writing its own Bollywood trilogy: “From Sugar to Jet Fuel: The Ethanol Empire Strikes Back.”
The only question is — will it be a blockbuster or another “budget overrun” sequel?
3. Business Model – WTF Do They Even Do?
TruAlt Bioenergy’s business model is like a buffet at a wedding — everything’s there, but you’re not sure what the main course is.
At its core, TruAlt is a biofuel company. It primarily produces 1G ethanol (first-generation) from molasses, sugar syrup, and sugarcane juice. That’s the part the government loves — because it reduces crude imports. But TruAlt didn’t stop there. It also makes extra neutral alcohol (ENA) for your favorite whisky brand, liquid CO₂, dry ice, power, and even compressed bio-gas (CBG) through its subsidiary, Leafiniti Bioenergy.
Revenue mix tells the story:
Ethanol – 75% (the core driver)
ENA – 15% (for the thirsty nation)
CBG – 1.2% (for green bragging rights)
CO₂ – 0.3% (for fizzy soda and storage)
Others – 8.5%
It operates five manufacturing units in Karnataka, with a total installed capacity of 2,000 KLPD and operational capacity of 1,800 KLPD — which alone accounts for 3.6% of India’s ethanol capacity. The company plans to convert 1,300 KLPD into dual-feed plants by FY26, allowing both sugar and grain inputs — because flexibility is the new sustainability.
Through Leafiniti, TruAlt is also one of India’s earliest participants in the SATAT initiative (Sustainable Alternative Towards Affordable Transportation), partnering with giants like Sumitomo and GAIL for 20+ new CBG plants.
In short: TruAlt wants to be Reliance for renewables. But the question remains — can it fuel profits as efficiently as it fuels India’s ethanol blending dreams?
4. Financials Overview
Source table
Metric (₹ Cr)
Q2 FY26 (Sep 2025)
Q2 FY25 (Sep 2024)
Q1 FY26 (Jun 2025)
YoY %
QoQ %
Revenue
115
388
304
-70.4%
-62.2%
EBITDA
-5
17
42
-129.4%
-111.9%
PAT
-37.9
-19
5
-99.5%
-860.0%
EPS (₹)
-4.42
-2.64
0.67
—
—
When your YoY and QoQ both scream red, it’s not a result — it’s a bloodbath. Revenue collapsed, profits evaporated, and margins turned negative.
If this were a distillery, TruAlt’s balance sheet just went from whisky to plain soda. The only silver lining? They’ve still got government blending demand and strong capacity in place — the machinery’s fine, the timing isn’t.
5. Valuation Discussion – Fair Value Range Only
Let’s calculate fair value ranges the educational way:
a) P/E Method FY25 EPS = ₹20.8 Industry average P/E = 19.6 Company P/E = 30.8 (premium due to growth story) → Fair Value Range (P/E) = ₹20.8 × (18–24) = ₹374–₹499
b) EV/EBITDA Method FY25 EBITDA = ₹309 crore Enterprise Value = ₹5,183 crore EV/EBITDA = 16.7× actual, vs peer median 13–15× → Fair Range = ₹4,000–₹4,600 crore EV → equity value ≈ ₹430–₹490 per share
c) Simplified DCF (using FY25 PAT ₹147 Cr, growth 15%, WACC 11%) Fair range ≈ ₹410–₹480
🎯 Educational Fair Value Range: ₹410 – ₹490 per share (Not investment advice. For educational purposes only.)
6. What’s Cooking – News, Triggers, Drama
The past 30 days for TruAlt looked like a political season finale. Here’s the highlight reel:
Nov 15, 2025: Signed MoU with Andhra Pradesh Govt (APEDB) to set up an ₹2,250 crore SAF plant (80,000 TPA) — a huge leap into jet fuel.
